SEMA3C and cancer: Recent research indicates that Semaphorin 3C (SEMA3C), a member of the semaphorin family, significantly contributes to cancer progression by promoting tumor growth, invasion, and metastasis in a variety of tumors including prostate, breast, lung, colorectal, ovarian, pancreatic and glioblastoma cancers [9,10,11].